The transport of immunoglobulins across mucous membranes is a selective process that involves different classes of immunoglobulins in different species (1) . In human external secretions, the principal immunoglobulin is secretory IgA (s-IgA). This molecule is the product of plasma cells that secrete polymeric IgA with J chain, and of epithelial cells that synthesize secretory component (SC). The SC becomes linked to the IgA during transport through the epithelial cells (2) . In some cases of IgA deficiency, secretory IgM (s-IgM) rather than s-IgA appears in external secretions (2, 3) . Several models of active transport proposed to explain the selective appearance of IgA and IgM in secretions suggest that initially these immunoglobulins are selectively bound to a receptor on the surface of exocrine epithelial cells (2, 4) . The possibility that SC may serve as an immunoglobulin receptor on epithelial cells is implied by the following findings: J chain-containing polymeric IgA and IgM molecules exhibit an in vitro affinity for SC (2) ; the infusion of an animal with anti-SC serum lowers the ratio of intestinal s-IgA to serum IgA (5); and immunofluorescence studies on tissue sections of the intestine reveal the coincidental appearance of SC and IgA on the basal and lateral surfaces of epithelial cells (2) .
The present studies were undertaken to determine whether SC is indeed a receptor for immunoglobulins of various classes, subclasses, and molecular configurations. The human epithelial cell line HT-29, which displays SC on the cell surface (6) , and sections of human fetal intestines were examined for their ability to bind various immunoglobulins on the cell membrane or in the cytoplasm.
Materials and Methods
Preparation of Immunoglobulins and SC. Secretory IgA from colostrum, and polymeric or monomeric IgA from sera of patients with IgA myelomatosis, and IgG from normal human serum were purified by ammonium sulfate precipitation, followed by molecular sieve chromatography on Sephadex G-200 and Sepharose 6B, and DEAE-cellulose chromatography as described in detail (7) . IgM proteins were purified from sera of patients with Waldenstr6m's macroglobulinemia by euglobulin precipitation with a 15-fold excess of cold distilled water and subsequent Sephadex G-200 gel filtration (8) . SC was purified by the method of Brandtzaeg (9) from colostrum and milk of normal mothers and a patient with panhypogammaglobulinemia. The purity of these preparations was determined by immunoelectrophoresis and double immunodiffusion with polyvalent * Supported by U.S. Public Health Service Research grants GM-07164, AI-10854, DE-02670, and CA-13148. antisera to human serum and colostrum (Behring Diagnostics, American Hoechst Corp., Sommerville, N.J.).
Reagents. Monovalent antisera (specific for the heavy (H) chains of IgA, IgM, or IgG) were prepared in this laboratory as previously described (7), or were obtained from a commercial source (Behring Diagnostics). Anti-SC reagents were prepared by adsorption of anti-s-IgA antisera with purified serum IgA (10) or by immunization of rabbits and goats with SC that was purified as described above; a commercially available rabbit anti-human SC was also used (Behring Diagnostics). Preparations of anti-J chain and anti-lactoferrin reagents have been described (7, 11) . Procedures used for the preparation and fluorochrome labeling of T-globulin fractions and F(ab')2 fragments of anti-SC and anti-H chain reagents have been described (12) .
Tissue and Cell Processing. Tissue from the small intestine was obtained from human fetuses (age determined by crown to rump measurements). Tissues were either immediately frozen in liquid nitrogen or were fixed in cold 95% ethanol and embedded in paraffin by the method of Sainte-Marie (13); frozen sections (4/~m) were fixed in 96 ml of 95% ethanol + 5 ml of glacial acetic acid. The presence of SC was determined by incubation with tetramethylrhodamineisothiocyanate (TRITC) labeled anti-SC. To determine the binding of immunoglobulins, tissue sections were incubated with TRITC-laboled monomeric or polymeric myeloma IgA, colostral IgA, macroglobulin IgM, or IgG.
A line of human epithelial cells, HT-29 (developed at the Sloan-Kettering Institute for Cancer Research, New York) was propagated in tissue culture and allowed to grow in monolayers, according to the technique of Huang et al. (6) . In some experiments, cells were recovered from monolayers by a 5-rain treatment at 37"C with 0.25% trypsin and 10 -2 M EDTA, washed, and then allowed to adhere to sterile glass cover slips for 48-72 h before examination. In other experiments, cells were scraped off the flask wall, washed, and resuspended in phosphate-buffered saline (PBS) + 1% bovine serum albumin + 0.3% sodium azide for immediate examination. Cultures were maintained in McCoy's Modified 5A medium (Grand Island Biological Co., Grand Island, N. Y.) that contained 15% fetal bovine serum (Reheis Chemical Co., Kankakee, Ill.), penicillin and streptomycin, and L-glutamine. All cultures were incubated at 37°C in 5% CO2.
The presence of SC on the cell membrane was determined with the fluorochrome-labeled F(ab')2 fragment of anti-SC reagents. Binding affinities were determined by incubation of cells with various immunoglobulin preparations (50 ftl of a solution containing 4 mg/ml) for 45 rain at room temperature. Cells were washed in PBS and then incubated with fluorochrome-labeled anti-H chain reagents or their F(ab')s fragments.
Cell suspensions were prepared as described by Winchester (12) , and all specimens were examined with a Leitz Orthoplan (Leitz, Wetzlar, Germany) fluorescence microscope equipped with epi-illumination.
Results
Immunoglobulin Binding by Intestinal Tissues. Sections of human small intestine obtained from fetuses at 8, 10, 11, 12, 131/2, 14, and 16 wk of gestation were examined by direct immunofluorescence for the presence of SC and endogenous immunoglobulins. Intestinal tissue sections incubated with labeled anti-H chain reagents alone exhibited no cellular fluorescence, which indicated that endogenous immunoglobulins were absent. SC was not detected in fetal tissues until the 16th-wk of gestation. These findings match those of Ogra et al. (14) as to the time of appearance of SC in human fetal development. At this stage, the epithelial cells fluoresced on staining with fluorochrome-labeled polymeric IgA (Fig. la) , whereas epithelial cells of tissue sections from younger fetuses (which displayed no SC) did not exhibit immunoglobulin binding. Specificity of the immunoglobulin binding (at 16 wk) was confirmed by the absence of fluorescence when the cells were pre-incubated with unlabeled polymeric IgA. TRITC-labeled monomeric IgA and serum IgG did not bind to the cytoplasm of epithelial cells from fetuses of any age. The fluorescence observed after incubation with fluorochrome-labeled IgM was weaker than with poly- 
Binding of Immunoglobulins to the Surface of Colonic Carcinoma Cells. HT-
29 cells attached to a cover slip or in single cell suspensions were examined for the presence of SC on the membrane and for their ability to bind immunoglobulins of various classes, subclasses, and molecular configurations. SC was expressed most prominently after 72 h of cultivation; at that time 35% of the cells fluoresced with labeled anti-SC reagents (Fig. lb) . Incubation of these cells with polymeric IgA myeloma proteins and subsequent addition of fluorescein isothiocyanate-labeled alpha chain specific antisera revealed immunoglobulin binding to the cell surface. Both IgA1 and IgA2 subclasses with kappa and lambda chains were included in these IgA myeloma proteins. Characteristics of these immunoglobulins and their capacities for binding to HT-29 cells are given in Table I 
Configuration determined by polyacylamide gel electrophoresis and ultracentrifugation (26) . S Presence of J chain determined by polyacylamide gel electrophoreeis and immunoelectrophoresis (26) . 
